[1] 吴在德. 外科学[M]. 6 版. 北京:人民卫生出版社,2004:460－465.
[2] Tulchinsky E. Fos family members:regulation,structure and role in oncogenic transformation[J]. Histol Histopathol,2000,15(3):921－928.
[3] Klein EA,Campbell LE,Kothapalli D,et al. Joint requirement for Rac and ERK activities underlies the mid-G1 phase induction of cyclin D1 and S phase entry in both epithelial and mesenchymal cells[J]. Biol Chem,2008,283(45):30911－30918.
[4] Milde-Langosch K. The Fos family of transcription factors and their role in tumourigenesis[J]. Eur J Cancer,2005,41(16):2449－2461.
[5] Hulboy DL,Matrisian LM,Crawford HC. Loss of Jun B activity enhances stromelysin 1 expression in a model of the epithelial-to-mesenchymal transition of mouse skin tumors[J]. Mol Cell Biol,2001,21(16):5478－5487.
[6] Belguise K,Kersual N,Galtier F,et al. Fra-1 expression level regulates proliferation and invasiveness of breast cancer cells[J].Oncogene,2005,24(8):1434－1444.
[7] Andersen H,Mahmood S,Tkach V,et al. The ability of Fos family members to produce phenotypic changes in epitheloid cells is not directly linked to their transactivation potentials[J]. Oncogene,2002,21(31):4843－4848.
[8] Ramos-Nino ME,Scapoli L,Martinelli M,et al. Microarray analysis and RNA silencing link Fra-1 to CD44 and c-met expression in mesothelioma[J]. Cancer Res,2003,63 (13):3539－3545.
[9] Kustikova O,Kramerov D,Grigorian M,et al. Fra-1 induces morphological transformation and increases in vitro invasiveness and mobility of epithelioid adenocarcinoma cells[J]. Mol Cell Biol,1998,18(12):7095－7105.
[10] 宋玉华,宋三泰,江泽飞,等. 原癌基因 Fra-1 高表达与乳腺癌细胞转移表型的关系[J]. 西安交通大学学报,2008,29(2):171－175.
[11] Chiappetta G,Ferraro A,Botti G,et al. Fra-1 protein overexpression is a feature of hyperplastic and neoplastic breast disorders[J]. BMC Cancer,2007,7:17.
[12] Hu YC,Lam KY,Law S,et al. Identification of differentially expressed genes in esophageal squamous cell carcinoma(ESCC) by cDNA expression array:overexpression of Fra-1,Neogenin,Id1,and CDC25B genes in ESCC[J]. Clin Cancer Res,2001,7(8):2213－2221.
[13] Chiappetta G,Tallini G,De Biasio M C,et al. Fra-1 expression in hyperplastic and neoplastic thyroid diseases[J]. Clin Cancer Res,2000,6(11):4300－4306.
[14] Wang HL,Wang J,Xiao SY,et al. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin[J]. Int J Cancer,2002,101(4):301－310.
[15] Serewko MM,Popa C,Dahler AL,et al. Alterations in gene expression and activity during squamous cell carcinoma development[J]. Cancer Res,2002,62(13):3759－3765.
[16] Tchernitsa OI,Sers C,Zuber J,et al. Transcriptional basis of KRAS oncogene-mediated cellular transformation in ovarian epithelial cells[J]. Oncogene,2004,23(26):4536－4555.
[17] Zhang L,Pan HY,Zhong LP,et al. Fos-related activator-1 is overexpressed in oral squamous cell carcinoma and associated with tumor lymph node metastasis[J]. J Oral Pathol Med,2010,39(6):470－476.